137 related articles for article (PubMed ID: 18264134)
1. Transforming pathways unleashed by a HDAC2 mutation in human cancer.
Ropero S; Ballestar E; Alaminos M; Arango D; Schwartz S; Esteller M
Oncogene; 2008 Jun; 27(28):4008-12. PubMed ID: 18264134
[TBL] [Abstract][Full Text] [Related]
2. A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition.
Ropero S; Fraga MF; Ballestar E; Hamelin R; Yamamoto H; Boix-Chornet M; Caballero R; Alaminos M; Setien F; Paz MF; Herranz M; Palacios J; Arango D; Orntoft TF; Aaltonen LA; Schwartz S; Esteller M
Nat Genet; 2006 May; 38(5):566-9. PubMed ID: 16642021
[TBL] [Abstract][Full Text] [Related]
3. An inactivating mutation in HDAC2 leads to dysregulation of apoptosis mediated by APAF1.
Hanigan CL; Van Engeland M; De Bruine AP; Wouters KA; Weijenberg MP; Eshleman JR; Herman JG
Gastroenterology; 2008 Nov; 135(5):1654-1664.e2. PubMed ID: 18834886
[TBL] [Abstract][Full Text] [Related]
4. Autoregulation of the N-myc gene is operative in neuroblastoma and involves histone deacetylase 2.
Kim MK; Carroll WL
Cancer; 2004 Nov; 101(9):2106-15. PubMed ID: 15382088
[TBL] [Abstract][Full Text] [Related]
5. The LIM-only factor LMO4 regulates expression of the BMP7 gene through an HDAC2-dependent mechanism, and controls cell proliferation and apoptosis of mammary epithelial cells.
Wang N; Lin KK; Lu Z; Lam KS; Newton R; Xu X; Yu Z; Gill GN; Andersen B
Oncogene; 2007 Sep; 26(44):6431-41. PubMed ID: 17452977
[TBL] [Abstract][Full Text] [Related]
6. Modulation of immunoglobulin gene conversion frequency and distribution by the histone deacetylase HDAC2 in chicken DT40.
Lin W; Hashimoto S; Seo H; Shibata T; Ohta K
Genes Cells; 2008 Mar; 13(3):255-68. PubMed ID: 18298800
[TBL] [Abstract][Full Text] [Related]
7. HDAC2 mediates therapeutic resistance of pancreatic cancer cells via the BH3-only protein NOXA.
Fritsche P; Seidler B; Schüler S; Schnieke A; Göttlicher M; Schmid RM; Saur D; Schneider G
Gut; 2009 Oct; 58(10):1399-409. PubMed ID: 19528037
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase HDAC1/HDAC2-controlled embryonic development and cell differentiation.
Brunmeir R; Lagger S; Seiser C
Int J Dev Biol; 2009; 53(2-3):275-89. PubMed ID: 19412887
[TBL] [Abstract][Full Text] [Related]
9. Negative and positive regulation of gene expression by mouse histone deacetylase 1.
Zupkovitz G; Tischler J; Posch M; Sadzak I; Ramsauer K; Egger G; Grausenburger R; Schweifer N; Chiocca S; Decker T; Seiser C
Mol Cell Biol; 2006 Nov; 26(21):7913-28. PubMed ID: 16940178
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylases 1 and 2 are expressed at distinct stages of neuro-glial development.
MacDonald JL; Roskams AJ
Dev Dyn; 2008 Aug; 237(8):2256-67. PubMed ID: 18651664
[TBL] [Abstract][Full Text] [Related]
11. Nitration of distinct tyrosine residues causes inactivation of histone deacetylase 2.
Osoata GO; Yamamura S; Ito M; Vuppusetty C; Adcock IM; Barnes PJ; Ito K
Biochem Biophys Res Commun; 2009 Jul; 384(3):366-71. PubMed ID: 19410558
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitor apicidin downregulates DNA methyltransferase 1 expression and induces repressive histone modifications via recruitment of corepressor complex to promoter region in human cervix cancer cells.
You JS; Kang JK; Lee EK; Lee JC; Lee SH; Jeon YJ; Koh DH; Ahn SH; Seo DW; Lee HY; Cho EJ; Han JW
Oncogene; 2008 Feb; 27(10):1376-86. PubMed ID: 17828306
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration.
Ito K; Hanazawa T; Tomita K; Barnes PJ; Adcock IM
Biochem Biophys Res Commun; 2004 Feb; 315(1):240-5. PubMed ID: 15013452
[TBL] [Abstract][Full Text] [Related]
14. Regulation of c-met expression by transcription repressor Daxx.
Morozov VM; Massoll NA; Vladimirova OV; Maul GG; Ishov AM
Oncogene; 2008 Apr; 27(15):2177-86. PubMed ID: 17952115
[TBL] [Abstract][Full Text] [Related]
15. Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2.
Lin YC; Lin JH; Chou CW; Chang YF; Yeh SH; Chen CC
Cancer Res; 2008 Apr; 68(7):2375-83. PubMed ID: 18381445
[TBL] [Abstract][Full Text] [Related]
16. Reduced body size and decreased intestinal tumor rates in HDAC2-mutant mice.
Zimmermann S; Kiefer F; Prudenziati M; Spiller C; Hansen J; Floss T; Wurst W; Minucci S; Göttlicher M
Cancer Res; 2007 Oct; 67(19):9047-54. PubMed ID: 17909008
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1.
Huang BH; Laban M; Leung CH; Lee L; Lee CK; Salto-Tellez M; Raju GC; Hooi SC
Cell Death Differ; 2005 Apr; 12(4):395-404. PubMed ID: 15665816
[TBL] [Abstract][Full Text] [Related]
18. Impairment of stromelysin-1 transcriptional activity by promoter mutations in high microsatellite instability colorectal tumors.
Morán A; Iniesta P; de Juan C; García-Aranda C; Díaz-López A; Benito M
Cancer Res; 2005 May; 65(9):3811-4. PubMed ID: 15867378
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility.
Montgomery RL; Davis CA; Potthoff MJ; Haberland M; Fielitz J; Qi X; Hill JA; Richardson JA; Olson EN
Genes Dev; 2007 Jul; 21(14):1790-802. PubMed ID: 17639084
[TBL] [Abstract][Full Text] [Related]
20. HDAC2 deficiency and histone acetylation.
Ree AH; Folkvord S; Flatmark K
Nat Genet; 2008 Jul; 40(7):812-3; author reply 813. PubMed ID: 18583969
[No Abstract] [Full Text] [Related]
[Next] [New Search]